The largest database of trusted experimental protocols

16 protocols using sc75741

1

Modulating Oncogenic HER2 Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
MCF7/NeuT cells were seeded onto a 6-well plate and allowed to attach overnight. On the next day, cells were treated with different concentrations of LY294002 (Selleckchem), PD98059 (Selleckchem), U73122 (Tocris), everolimus (Selleckchem) or CHIR-99021 (Selleckchem). For induction of the oncogenic rat HER2 variant, NeuT in the MCF7 cells, doxycycline (Sigma) was added with a final concentration of 1 µg/ml per well to one half of the experiment setup one hour after the inhibitor addition [16 (link)]. Medium was changed every three days, and cells were harvested after three and seven days, for RNA and protein expression analyses as described above.
For the EDI3 expression studies in endogenous HER2 expressing cell lines, SKBR3 and HCC1954 cells were seeded onto a 6-well plate and allowed to attach overnight. On the next day, cells were treated with different concentrations of lapatinib, everolimus, CHIR-99021, compound 3i (666–15), C188-9, KC7F2, SC75741, 10074-G5 or SR18662 (all from Selleckchem). After one, two and three days (as well as 4 days for lapatinib), cells were harvested at approximately 80% confluency for RNA and protein expression analyses as described above. Medium was changed after two days.
+ Open protocol
+ Expand
2

Effects of NFκB Inhibitor SC75741 on Bladder Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
SC75741, an NFκB inhibitor involving impaired DNA binding of the NFκB subunit p65 [41 (link)], was purchased from Selleck Chemicals (Houston, TX, USA). A Western blot assay was conducted with bladder cancer cells exposed to ionizing irradiation of 5 Gy either alone or combined with 5 μM of SC75741 for 24 h. Cells were treated with different doses of SC75741 and irradiation, and incubated for 7 days for colony formation assays.
+ Open protocol
+ Expand
3

P. gingivalis Infection Model in OCCM-30 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
P. gingivalis, strain ATCC 33277, was maintained in the brain heart infusion broth, with supplement of yeast extract (1 mg/ml), hemin (5 mg/ml) and menadione (1 mg/ml) in an anaerobic condition (85 % N2, 5 % H2, and 10 % CO2) at 37 °C. Bacterial levels were normalized using a spectrophotometer (SpectraMax M3, USA) to an optical density (OD) of 1 at 600 nm, equivalent to 109 CFU/ml [25 (link)]. P. gingivalis infected OCCM-30 cells at the exponential growth phase with varying multiplicity of infection (MOI = 30, 100 and 300) as detailed in the figure captions.
Mito-Tempo (MedChemExpress, USA), the mtROS scavenger, MCC950 (MedChemExpress, USA), the selective NLRP3 inhibitor, and SC75741 (Selleck, USA), the nuclear factor-kappa B (NF-κB) inhibitor were used at the concentration of 100 μM or 5 μM respectively for 2 h before the experiment.
+ Open protocol
+ Expand
4

Investigating Inflammatory Response in Bladder Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
RAW 264.7 macrophages and T24 cells were purchased from the ATCC (Rockville, MD, USA). Antibodies for western blotting were purchased from Cell Signaling Technologies (Pickering, ON, CAN), including those targeting P65, P-P65, TAK1, iKKa/b, INOS, COX2, IKB, p-IKB, NLRP3, Caspase-1, and GAPDH. Secondary antibodies for western blotting and 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide (MTT) were purchased from Sigma (Sigma Aldrich, St. Louis, MO, USA). Transitional cell carcinoma of the bladder cells (T24 cells) and a mouse macrophage cell line (RAW 264.7 macrophages) were purchased from the American Type Culture Collection (Rockville, MD, USA). Fetal bovine serum (FBS), Dulbecco's modified Eagle's medium (DMEM) and penicillin/streptomycin solution were purchased from HyClone (Logan, UT, USA). Phycoerythrin (PE)-conjugated anti-CD80 and fluorescein isothiocyanate (FITC)-conjugated anti-mouse CD282, PE-IgG2a and FITC-IgG2a antibodies, were purchased from BD Systems (BD Biosciences, USA). ProcartaPlexTM Multiplex Immunoassay Kits were purchased from eBioscience (San Diego, CA, USA). DEAE-52 and Sephadex G-100 gel filtration medium were purchased from GE Healthcare Bio-Sciences AB (UPPPala, Sweden). SC75741 (purity, 99.79%) was purchased from Selleck (Shanghai, China).
+ Open protocol
+ Expand
5

Regulation of Hedgehog and NF-κB Pathways in BMECs

Check if the same lab product or an alternative is used in the 5 most similar protocols
In this study, 0.1 μM GANT61 (Selleck, Cat# S8075), which is an inhibitor of Gli (Lauth, Bergstrom, Shimokawa, & Toftgard, 2007), was used to inhibit the Hedgehog pathway. The drug was dissolved in cell culture medium with 0.1% dimethyl sulfoxide (Sigma‐Aldrich, Cat# D2650). The BMECs were randomly separated into three groups: (1) the untreated control group, which was incubated with cell medium; (2) the mimic group, which was incubated with 50 nM miRNA‐9‐5p mimic; and (3) the M + G group, which was incubated with 50 nM miRNA‐9‐5p mimic and 0.1 μM GANT61. All groups were incubated in both normal and OGD state for 24 hr before testing.
In addition, 200nM SC75741 (Selleck, Cat# S7273) was also used to inhibit the activation of NF‐κB in BMECs (Zhong et al., 2020). The BMECs were randomly separated into four groups: (1) the untreated control group; (2) the mimic group, which was incubated with 50 nM miRNA‐9‐5p mimic; (3) the inhibitor group, which was incubated with 100 nM miRNA‐9‐5p inhibitor; and (4) the inhibitor + SC group, which was incubated with 100 nM miRNA‐9‐5p inhibitor and 200 nM SC75741. All cells were incubated at 37°C with 5% carbon dioxide for 24 hr before testing.
+ Open protocol
+ Expand
6

FOXP3 Modulates CD69 Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human CD4+ T cells were transduced either with an empty control vector (co‐tg) or a FOXP3‐encoding vector (FOXP3‐tg), both harboring an IRES‐GFP site. After transduction, cells were FACS‐sorted for GFP expression and activated with anti‐CD3/anti‐CD28 microbeads (cells : beads = 2 : 1) in the absence or presence of the NF‐κB inhibitor SC75741 (1.875 µm, 3.75 µm, or 7.5 µm; Selleckchem, Houston, TX, USA). After 24 h, surface expression of the early activation marker CD69 was measured by FACS analysis. Expression levels of SC7 treated co‐tg and FOXP3‐tg cells were normalized to those of co‐tg and FOXP3‐tg cells activated without SC7, respectively.
+ Open protocol
+ Expand
7

Investigating Macrophage and Cell Line Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
The mouse macrophage cell lines RAW 264.7, human monocytic leukemia THP-1, and transitional cell carcinoma of the bladder cell line T24 were purchased from ATCC (Rockville, MD, USA). Specific monoclonal antibodies, including antibodies against iNOS, NLRP3, IκB-α, p-IκB, p-Iκκ-α/β, Cox2, p65, p-P65 and GAPDH, were purchased from Cell Signaling Technology Inc. (Beverly, MA, USA). Secondary antibodies for western blotting and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were purchased from Sigma (Sigma Aldrich, St. Louis, USA). Fetal bovine serum (FBS), Dulbecco’s modified Eagle’s medium (DMEM) and penicillin/streptomycin solution were purchased from HyClone (Logan, UT, USA). Phycoerythrin (PE)-conjugated anti-CD40, CD16/32, fluorescein isothiocyanate (FITC)-conjugated anti-mouse CD282 and FITC-IgG2a antibodies were purchased from BD Systems (BD Biosciences, USA). ProcartaPlex Multiplex Immunoassay Kits were purchased from eBioscience (San Diego, CA, USA). DEAE-52 and Sephadex G-100 gel filtration medium was purchased from GE Health Care BioSciences AB (UPPPala, Sweden). SC75741 (purity, 99.79%) was purchased from Selleck (Shanghai, China).
+ Open protocol
+ Expand
8

Culturing CML Cell Lines with Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
The JURL-MK114 (link) and K56215 (link) CML lines were obtained from the German Collection of Microorganisms and Cell Cultures (DSMZ) and cultured in RPMI 1640 medium containing 10% heat-inactivated fetal bovine serum, and 1 mM L-glutamine (complete medium). The cell lines were PCR-tested and found to be mycoplasma free.
Recombinant human IFNγ (PeproTech) was dissolved as recommended by the manufacturer. Imatinib (17 mM stock; Sigma-Aldrich) and ralimetinib (10 mM stock; Selleckchem) were dissolved in water. Wortmannin (10 mM stock; Selleckchem), SCH772984 (10 mM stock; Selleckchem), JNK-IN-8 (25 mM stock; Selleckchem), and SC75741 (20 mM stock; Selleckchem) were dissolved in dimethyl sulfoxide (DMSO). DMSO concentration was equalized in each well of a particular experiment.
+ Open protocol
+ Expand
9

Expansion of Human Regulatory T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human PB Treg were FACS‐sorted as described above. Directly after sorting, 2 × 105 Treg were incubated with either 100 U·mL−1 IL‐2 alone or 100 U·mL−1 IL‐2 + 3.75 µm SC75741 (Selleckchem). After 1‐h pre‐incubation, cells were stimulated with anti‐CD3/anti‐CD28 microbeads (cells : beads = 2 : 1). After 4 days of culture, cells were extensively washed in SC7‐free medium, FACS‐sorted for viable cells, and used for further coculture experiments.
+ Open protocol
+ Expand
10

Evaluating NF-κB Inhibition on Cell Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
A Cell Counting Kit-8 (CCK-8; Dojindo Molecular Technologies, Inc., Kumamoto, Japan) assay was used to assess the cell proliferation ability. A total of 1,000 cells were plated and adhered onto 96 well plates and optical density values at 450 nm were measured subsequent to adding CCK-8 (incubation for 2 h at 37°C) on day 1, 2, 3, 4, 5 and 6. B-CPAP/KLF5 cells were cultured with medium containing NF-κB inhibitor SC75741 (5 μM; Selleck Chemicals, Houston, TX, USA) or vehicle [dimethyl sulfoxide (DMSO; Sangon Biotech Co., Ltd., Shanghai, China)] for 1, 2, 3, 4, 5 and 6 days (at 37°C) to evaluate the influence of NF-κB on cell proliferation.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!